IMR Press / FBL / Volume 13 / Issue 3 / DOI: 10.2741/2726

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article
Inositol polyphosphate multikinase: metabolic architect of nuclear inositides
Show Less
1 Division of Neurosurgery at the Children's Hospital of Philadelphia, Department of Neurosurgery at the University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
2 Medical Research Council (MRC) Cell Biology Unit and Laboratory for Molecular Cell Biology, Department of Biochemistry and Molecular Biology, University College London, Gower Street, London WC1E 6BT, United Kingdom
Front. Biosci. (Landmark Ed) 2008, 13(3), 856–866; https://doi.org/10.2741/2726
Published: 1 January 2008
Abstract

The inositides are key cellular second messengers with well established roles in signal transduction pathways initiated by cell surface receptor activation. The recent identification of an evolutionarily conserved nuclear signaling pathway for higher inositol polyphosphates has defined a new signaling paradigm for this diverse class of molecules whose biosynthesis and regulation is mediated by what are likely some of the earliest ancestors of the inositide kinase families. Inositol polyphosphate multikinase (IPMK) represents the most catalytically diverse member of this family with critical roles in nuclear functions including mRNA export, transcriptional regulation, and chromatin remodeling.

Share
Back to top